Blog The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult
People living with vasculitis rely on support, research, and connection every day.
Today only, your donation will be matched dollar-for-dollar, helping us reach more patients, fund critical research, and ensure no one faces vasculitis alone.